BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28502575)

  • 21. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].
    Di Stefano F; Giorgi Rossi P; Carozzi F; Ronco G; Cacciani L; Vecchi S; Naldoni C; Segnan N;
    Epidemiol Prev; 2017; 41(2):116-124. PubMed ID: 28627153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018.
    Garrido CO; Coşkun RA; Lent AB; Calhoun E; Harris RB
    Cancer Causes Control; 2020 Sep; 31(9):839-850. PubMed ID: 32602058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
    Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
    Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confusion about Pap smears: lack of knowledge among high-risk women.
    Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
    J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.
    Kamineni A; Tiro JA; Beaber EF; Silverberg MJ; Wheeler CM; Chao CR; Chubak J; Skinner CS; Corley DA; Kim JJ; Balasubramanian BA; Paul Doria-Rose V;
    Int J Cancer; 2019 Mar; 144(6):1460-1473. PubMed ID: 30353911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine.
    Higgins LM; Dirksing KN; Ding L; Morrow CD; Widdice LA; Kahn JA
    Hum Vaccin Immunother; 2016 Jun; 12(6):1498-503. PubMed ID: 26934107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cervical and breast cancer screening among immigrant women resident in Italy].
    Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
    Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cervical cancer screening with primary HPV-DNA test in the Local Health Authority 2 of Savona (Liguria Region, Northern Italy): a population-based study].
    Depetrini E; Bonelli L; Ardoino S; Cirucca MC; Contin R; De Leonardis D; Errigo V; Lugani A; Franco A; Pastorino A; Carrozzi G; Venturino E
    Epidemiol Prev; 2016; 40(3-4):171-8. PubMed ID: 27436250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How Is Health Literacy Related to Pap Testing Among US Women?
    Thompson EL; Wheldon CW; Vamos CA; Griner SB; Daley EM
    J Cancer Educ; 2019 Aug; 34(4):789-795. PubMed ID: 29931455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008-2013.
    Sauer AG; Jemal A; Simard EP; Fedewa SA
    Cancer Epidemiol; 2015 Aug; 39(4):650-5. PubMed ID: 26055147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Mills JM; Morgan JR; Dhaliwal A; Perkins RB
    Gynecol Oncol; 2021 Aug; 162(2):308-314. PubMed ID: 34090706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women.
    Restivo V; Costantino C; Marras A; Napoli G; Scelfo S; Scuderi T; Casuccio A; Cernigliaro A; Giusti A; Spila Alegiani S
    Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30131461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
    Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge About Cervical Cancer Risk Factors and Practices of Pap Testing Among Turkish Immigrant Women in the United States.
    Uysal Toraman A; Yildirim N
    J Immigr Minor Health; 2018 Oct; 20(5):1222-1229. PubMed ID: 28929252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.
    Saraiya M; McCaig LF; Ekwueme DU
    Am J Manag Care; 2010 Jun; 16(6):e137-44. PubMed ID: 20536271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.